Intrathecal Ziconotide and Morphine for Pain Relief: A Case Series of Eight Patients with Refractory Cancer Pain, Including Five Cases of Neuropathic Pain

INTRODUCTION: Studies have shown that, at low doses and with careful titration, combination therapy with intrathecal ziconotide and morphine results in rapid control of opioid-refractory cancer pain. However, there is a lack of published data regarding the efficacy and safety of intrathecal ziconoti...

Descripción completa

Detalles Bibliográficos
Autores principales: de la Calle Gil, Ana Bella, Peña Vergara, Isaac, Cormane Bornacelly, María Auxiliadora, Pajuelo Gallego, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685866/
https://www.ncbi.nlm.nih.gov/pubmed/26563119
http://dx.doi.org/10.1007/s40120-015-0035-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685866/
https://www.ncbi.nlm.nih.gov/pubmed/26563119
http://dx.doi.org/10.1007/s40120-015-0035-z

Ejemplares similares